
Фармсинтез LIFE
Фармсинтез Deferred Tax Liabilities Non Current 2007-2025 | LIFE
Annual Deferred Tax Liabilities Non Current Фармсинтез
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 238 K | 32.4 M | 251 K | 177 M | 15.4 M | - | - | - | 11 M | 3.41 M | 572 K | 4.12 M | 1.7 M |
All numbers in RUB currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 177 M | 238 K | 24.6 M |
Quarterly Deferred Tax Liabilities Non Current Фармсинтез
| 2023-Q2 | 2022-Q4 | 2022-Q2 | 2021-Q4 | 2021-Q2 | 2020-Q4 | 2020-Q2 | 2019-Q4 | 2019-Q2 | 2018-Q4 | 2018-Q2 | 2017-Q4 | 2017-Q2 | 2016-Q4 | 2016-Q2 | 2015-Q4 | 2015-Q2 | 2014-Q4 | 2014-Q2 | 2013-Q4 | 2013-Q2 | 2012-Q4 | 2011-Q4 | 2011-Q2 | 2010-Q4 | 2010-Q2 | 2009-Q4 | 2009-Q2 | 2008-Q4 | 2008-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 238 K | 32.8 M | - | 274 K | 251 K | - | 177 M | - | - | - | - | 8.56 M | - | -5.07 M | - | 11 M | 7.21 M | 3.41 M | 1.99 M | 572 K | 2.35 M | 4.12 M | 2.91 M |
All numbers in RUB currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 177 M | -5.07 M | 16.5 M |